Abstract:BACKGROUND:Infantile haemangiomas (IHs) are the most common vascular tumours of infancy. Topical therapies are a possible treatment for superficial IHs.AIM:To determine the efficacy and safety of topical therapy in the treatment of superficial proliferating IHs.METHODS:The medical records of all the patients with proliferating superficial IHs were reviewed. All lesions had been treated either with imiquimod 5% cream or timolol 0.5% ophthalmic solution. Lesions were classified into pairs, with one of each treatment in each pair, matched by anatomical location, colour and size. A visual analogue scale (VAS) and the Haemangioma Activity Score (HAS) were used to evaluate the efficacy of the two drugs. The paired Student t-test was used to test for differences in recovery with these two treatments.RESULTS:In total, 51 patients treated with timolol and 94 treated with imiquimod met the inclusion criteria, and 20 lesions treated with timolol were successfully matched to a lesion treated with imiquimod. The paired t-test indicated that there was no significant difference in either VAS score (P = 0.11) or HAS (P = 0.49). For the imiquimod-treated patients, crusting was the most common reaction (65.0%, 13/20). This did not cause any superficial scarring or skin pigmentation in the matched pairs; however, superficial scars (14.9%, 14/94) and skin pigmentation disorders (28.7%, 27/94) were reported for some of the unmatched cases. There were no adverse events (AEs) during the treatment with timolol.CONCLUSIONS:Both imiquimod 5% cream or timolol 0.5% ophthalmic solution showed equivalent clinical efficacy after 4 months of treatment. Timolol appeared to have fewer AEs than imiquimod in the management of superficial IHs. Larger, prospective controlled trials with long-term treatment are needed to confirm these results.

Predictors of Treatment Responses of Superficial Infantile Hemangiomas to Topical Timolol.

Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma.

Topical Timolol Vs. Oral Propranolol for the Treatment of Superficial Infantile Hemangiomas

A prospective self-controlled study of topical timolol 0.5% cream for large superficial infantile hemangiomas.

The Effect of 0.5% Topical Timolol Cream on Regression of Superficial Infantile Haemangioma in the Involuting Phase: a Prospective, Randomized, Self-Controlled Study

Effect of Timolol Maleate Gel-forming Solution in the Treatment of Superficial Infantile Hemangiomas: a Prospective, Randomized, Double-Blind, Controlled Trial

Imiquimod 5% Cream Versus Timolol 0.5% Ophthalmic Solution for Treating Superficial Proliferating Infantile Haemangiomas: a Retrospective Study

Prospective, Open-Label, Rater-Blinded and Self-Controlled Pilot Study of the Treatment of Proliferating Superficial Infantile Hemangiomas with 0.5% Topical Timolol Cream Versus 595-Nm Pulsed Dye Laser

Open-Label Nonrandomized Left-Right Comparison of Imiquimod 5% Ointment and Timolol Maleate 0.5% Eye Drops in the Treatment of Proliferating Superficial Infantile Hemangioma

Efficacy and Safety of Oral Propranolol or Topical Timolol for the Treatment of Superficial Infantile Hemangiomas

[Topical Timolol in the Treatment of Periocular Superficial Infantile Hemangiomas: a Prospective Study].

Comparison of Simply Topical Timolol 0.5% Cream and Combined with Intralesional Diprospan Injection for the Treatment of Thick Superficial Infantile Hemangiomas

A Self‐controlled Study of Intralesional Injection of Diprospan Combined with Topical Timolol Cream for Treatment of Thick Superficial Infantile Hemangiomas

Fractional Carbon Dioxide Laser-Assisted Drug Delivery of Topical Timolol Solution for the Treatment of Deep Infantile Hemangioma: a Pilot Study.

Comparison of Oral Propranolol Alone and Combined with Topical 0.5 ％ Timolol Maleate Cream for the Treatment of Infantile Hemangiomas

Chinese Expert Consensus on the Use of Topical Timolol Maleate Treatment of Infantile Hemangiomas

Spectral Doppler Ultrasound for Predicting Long‐term Response to Topical Timolol in Children with Infantile Hemangioma

Evaluation of Transdermal Transport and Concurrent Cutaneous Hydrolysis of Timolol Prodrug for the Treatment of Infantile Hemangiomas

The efficacy and safety of treatments for infantile hemangiomas: a Bayesian network meta-analysis

The Efficacy and Safety of Treatments for Infantile Hemangiomas: a Bayesian Network Meta‐analysis

Topical Propranolol Hydrochloride Gel for Superficial Infantile Hemangiomas